The combined vaccine elicited higher immune response against SARS-CoV-2.
Plaque growth can lead to a higher risk of heart attack, stroke, and other life-threatening cardiovascular events for as long as 1 year.
Post-exertional malaise, or exercise intolerance, was seen in 36% of those with long COVID.
Get weekly COVD-19 updates in your inbox.
Catch the latest episode!
Top COVID FAQs
By CIDRAP & other experts
Read all 7 reports
The vast majority of the world is still susceptible to the virus, the WHO director says.
A study late last week found that convalescent plasma (CP) treatment did not significantly reduce mortality, but improved hospital discharge rates for patients 65 and older. The study in Clinical Infectious Diseases is one of the first to analyze clinical outcomes for closely matched cohorts of CP and control patients.
Since May 10, the US rate has exceeded that of all other nations studied.
The data offer hope for disease protection, but persistence was not analyzed beyond 4 months.
A trio of studies look at young adults' actions and consequences during the pandemic.
Cases are rising in 28 states, and details on Trump's illness are still murky.
Remdesivir helped patients recover faster, but hydroxychloroquine, again, did not prevent death.
In 2000, Europe imported 31% of drug materials from Asia; the number has now grown to 63%.
Several European nations report new daily highs, and hospital cases are rising in France.
Studies find that women, older people, and the conscientious tended to adhere better.
